Stanford licenses promising cancer drug to local biotech startup

Thursday, 25 September 2014

SFGateStanford licenses promising cancer drug to local biotech startupSFGateMost cancer patients don't die because of a single tumor, but rather multiple tumors that spread throughout the body. A new therapy, developed by Stanford University researchers and licensed by a local biotech startup, appears to disrupt the deadly ...